SLC1A2 and Alzheimer disease: Despite an often postsynaptic-centric view of the consequences of glutamate spillover in disease [65], we reveal a presynaptic vulnerability to GLT-1 impairment in the 3xTg model of AD that opposes short-term potentiation at CA3-CA1 synapses.